Compare JOBY & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JOBY | LNTH |
|---|---|---|
| Founded | 2009 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 6.6B |
| IPO Year | 2020 | 2014 |
| Metric | JOBY | LNTH |
|---|---|---|
| Price | $5.42 | $100.24 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 11 | 10 |
| Target Price | $10.45 | ★ $107.74 |
| AVG Volume (30 Days) | ★ 19.0M | 835.6K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.91 |
| Revenue | $53,425,000.00 | ★ $343,374,000.00 |
| Revenue This Year | $123.72 | N/A |
| Revenue Next Year | $83.31 | $10.29 |
| P/E Ratio | ★ N/A | $34.41 |
| Revenue Growth | ★ 39183.09 | 3.62 |
| 52 Week Low | $5.58 | $50.16 |
| 52 Week High | $18.77 | $111.86 |
| Indicator | JOBY | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 25.34 | 50.16 |
| Support Level | N/A | $99.92 |
| Resistance Level | $6.57 | $101.05 |
| Average True Range (ATR) | 0.22 | 0.36 |
| MACD | -0.02 | 0.09 |
| Stochastic Oscillator | 10.45 | 88.99 |
Joby Aviation Inc is a transportation company developing an all-electric, vertical take-off and landing (eVTOL) air taxi for commercial passenger service. Its Joby eVTOL aircraft is designed to transport a pilot and up to four passengers or an expected payload of up to 1,000 pounds at speeds of up to 200 mph. The aircraft is optimized for urban routes, with a target range of up to 100 miles on a single charge. The company is also developing an app-based platform that will help consumers to book rides directly through its service. It has one operating and reportable segment, air transportation and related services. The company's revenue consists of passenger revenue, which includes revenue generated from the transportation of passengers via helicopter or fixed wing aircraft.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.